NASDAQ · CRON

Cronos Group Inc.. Common

$2.86 +$0.05 (+1.78%) 1D After hours

Key Metrics

$1.05B
Market cap
P/E · TTM
$159.54M
Revenue · TTM
−$1.82M
Net income
EPS · TTM $0.00
Dividend yield
Free cash flow $26.53M
Beta · 1Y 0.82
EBITDA · TTM $8.87M
Gross margin 42.7%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 11
    The stock moved +8.3% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 11

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$1.05B
Enterprise value
Shares outstanding373.7M
52-wk range$1.93 – $3.43
Avg volume · 20D2.2M
Net cash
Book value / share$2.77
IndustryMedicinal Chemicals & Botanical Products
ExchangeNASDAQ
About Cronos Group Inc.. Common
IPO dateJun 3, 2016
Employees610

Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is building an iconic brand portfolio.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S6.58
P/FCF39.58
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross 42.7%
Operating -3.9%
Net -1.1%
FCF 16.6%
ROE / ROIC -0.2% · 2.0%

Financial Health

Current ratio21.87
Quick ratio20.73
Debt / equity
Debt / EBITDA
Net cash
Working capital$885.46M

Cash Flow · TTM

Operating CF $38.86M
Capex −$12.33M
Free cash flow $26.53M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

5 / 9
Middling fundamentals · 5 of 9 signals passing

Altman Z-Score

14.6
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings